Laurus Labs Limited
LAURUSLABS
Κατάταξη σε μετοχές
#1744
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Τιμή μετοχής
$22.80
Κεφαλαιοποίηση
$12.32B
Αλλαγή (1 ημέρα)
0.36%
Αλλαγή (1 έτος)
122.99%
Χώρα
IN
Εμπόριο Laurus Labs Limited (LAURUSLABS)
Κατηγορία
Healthcare
EPS για Laurus Labs Limited (LAURUSLABS)
EPS στις June 2026 TTM: $0.22
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή της μετοχής της Laurus Labs Limited, το τρέχον EPS της εταιρείας (TTM) είναι $0.22. Στο τέλος του 2024, η εταιρεία είχε EPS $0.04, μείωση σε σύγκριση με το EPS του 2023 που ήταν $0.18.
Ιστορικό EPS της Laurus Labs Limited από 2013 έως 2026
EPS στο τέλος κάθε έτους
| Έτος | EPS | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $0.22 | 179.38% |
| 2025 | $0.08 | 117.93% |
| 2024 | $0.04 | -80.03% |
| 2023 | $0.18 | -11.96% |
| 2022 | $0.20 | -19.02% |
| 2021 | $0.25 | 294.34% |
| 2020 | $0.06 | 149.41% |
| 2019 | $0.03 | -47.64% |
| 2018 | $0.05 | -24.02% |
| 2017 | $0.06 | -0.62% |
| 2016 | $0.06 | 82.20% |
| 2015 | $0.04 | -4.07% |
| 2014 | $0.04 | -30.64% |
| 2013 | $0.05 | 0.00% |
EPS για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | EPS | Διαφορά EPS | Χώρα |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 148.90% |
IN
|
